Regtechtimes on MSN1d
Japanese Astellas Employee Faces Prolonged Detention in China Without Explanation
A Japanese man working for Astellas Pharma Inc. in China was taken into custody by Chinese authorities, and it has now been ...
The Japan Times1d
During visit to Beijing, CDP delegates affirm importance of Japan-China ties
Former CDP Secretary-General Katsuya Okada has called for stepping up interaction between 'high-level' Japanese and Chinese ...
The Japan News3d
Detention of Japanese Astellas Pharma Employee in China May be Prolonged; Specific Actions that Led to Detention Not Revealed by Beijing
A Japanese man, who was detained by Chinese authorities, will likely continue to remain in detention despite the Japanese ...
FibroGen, Inc.: FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results
Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 million Transaction expected to close by mid-2025 Upon close of sale of FibroGen China, cash runway exte ...